| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |